Accelerated Enrollment DMD Case Study

Accelerated enrollment in a DMD study enables ahead-of-schedule delivery for small biotech

For a small biotech, completing accelerated enrollment and delivering ahead of schedule were priorities for a Duchenne muscular dystrophy study. By partnering with the PPD clinical research business of Thermo Fisher Scientific these goals were achieved through meticulous site selection, identifying eligible patients and alleviating burden on participating families.